インスリン有効成分のグローバル市場調査 2019年

• 英文タイトル：Global Insulin Active Pharmaceutical Ingredient Market Professional Survey Report 2019

• レポートコード：QYR9NV06910 • 出版社/出版日：QYResearch / 2019年11月12日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア

• 販売価格（消費税別）

Single User	￥525,000 (USD3,500)	▷ お問い合わせ
Enterprise License	￥1,050,000 (USD7,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※本調査レポートは、インスリン有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、化学合成、動物エキスに、用途別には、動物インスリン、一般ヒトインスリン、インスリンアナログにセグメント区分し、インスリン有効成分の世界市場を分析しました。 ・エグゼクティブ・サマリー ・インスリン有効成分の世界市場概要 ・インスリン有効成分の製造コスト構成分析 ・インスリン有効成分の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・インスリン有効成分の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・インスリン有効成分のセグメント分析（種類別） （化学合成、動物エキス） ・インスリン有効成分のセグメント分析（用途別） （動物インスリン、一般ヒトインスリン、インスリンアナログ） ・インスリン有効成分の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Novo Nordisk、Eli Lilly、Tong Hua Dong Bao Group、Wanbang Biopharmaceuticals、） ・インスリン有効成分の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ...

The global Insulin Active Pharmaceutical Ingredient market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Insulin Active Pharmaceutical Ingredient volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Active Pharmaceutical Ingredient market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Active Pharmaceutical Ingredient in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Active Pharmaceutical Ingredient manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Eli Lilly
Tong Hua Dong Bao Group
Wanbang Biopharmaceuticals
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Chemical Synthetics
Animal Extracts

Segment by Application
Animal Insulin
Regular Human Insulin
Insulin Analogue

レポート目次

---

Table of Contents

Executive Summary
1 Industry Overview of Insulin Active Pharmaceutical Ingredient
1.1 Definition of Insulin Active Pharmaceutical Ingredient
1.2 Insulin Active Pharmaceutical Ingredient Segment by Type
1.2.1 Global Insulin Active Pharmaceutical Ingredient Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Chemical Synthetics
1.2.3 Animal Extracts
1.3 Insulin Active Pharmaceutical Ingredient Segment by Applications
1.3.1 Global Insulin Active Pharmaceutical Ingredient Consumption Comparison by Applications (2014-2025)
1.3.2 Animal Insulin
1.3.3 Regular Human Insulin
1.3.4 Insulin Analogue
1.4 Global Insulin Active Pharmaceutical Ingredient Overall Market
1.4.1 Global Insulin Active Pharmaceutical Ingredient Revenue (2014-2025)
1.4.2 Global Insulin Active Pharmaceutical Ingredient Production (2014-2025)
1.4.3 North America Insulin Active Pharmaceutical Ingredient Status and Prospect (2014-2025)
1.4.4 Europe Insulin Active Pharmaceutical Ingredient Status and Prospect (2014-2025)
1.4.5 China Insulin Active Pharmaceutical Ingredient Status and Prospect (2014-2025)
1.4.6 Japan Insulin Active Pharmaceutical Ingredient Status and Prospect (2014-2025)
1.4.7 Southeast Asia Insulin Active Pharmaceutical Ingredient Status and Prospect (2014-2025)
1.4.8 India Insulin Active Pharmaceutical Ingredient Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Insulin Active Pharmaceutical Ingredient
2.3 Manufacturing Process Analysis of Insulin Active Pharmaceutical Ingredient
2.4 Industry Chain Structure of Insulin Active Pharmaceutical Ingredient

3 Development and Manufacturing Plants Analysis of Insulin Active Pharmaceutical Ingredient
3.1 Capacity and Commercial Production Date
3.2 Global Insulin Active Pharmaceutical Ingredient Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Insulin Active Pharmaceutical Ingredient
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Insulin Active Pharmaceutical Ingredient Production and Capacity Analysis
4.2 Insulin Active Pharmaceutical Ingredient Revenue Analysis
4.3 Insulin Active Pharmaceutical Ingredient Price Analysis
4.4 Market Concentration Degree

5 Insulin Active Pharmaceutical Ingredient Regional Market Analysis
5.1 Insulin Active Pharmaceutical Ingredient Production by Regions
5.1.1 Global Insulin Active Pharmaceutical Ingredient Production by Regions
5.1.2 Global Insulin Active Pharmaceutical Ingredient Revenue by Regions
5.2 Insulin Active Pharmaceutical Ingredient Consumption by Regions
5.3 North America Insulin Active Pharmaceutical Ingredient Market Analysis
5.3.1 North America Insulin Active Pharmaceutical Ingredient Production
5.3.2 North America Insulin Active Pharmaceutical Ingredient Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Insulin Active Pharmaceutical Ingredient Import and Export
5.4 Europe Insulin Active Pharmaceutical Ingredient Market Analysis
5.4.1 Europe Insulin Active Pharmaceutical Ingredient Production
5.4.2 Europe Insulin Active Pharmaceutical Ingredient Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Insulin Active Pharmaceutical Ingredient Import and Export
5.5 China Insulin Active Pharmaceutical Ingredient Market Analysis
5.5.1 China Insulin Active Pharmaceutical Ingredient Production
5.5.2 China Insulin Active Pharmaceutical Ingredient Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Insulin Active Pharmaceutical Ingredient Import and Export
5.6 Japan Insulin Active Pharmaceutical Ingredient Market Analysis
5.6.1 Japan Insulin Active Pharmaceutical Ingredient Production
5.6.2 Japan Insulin Active Pharmaceutical Ingredient Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Insulin Active Pharmaceutical Ingredient Import and Export
5.7 Southeast Asia Insulin Active Pharmaceutical Ingredient Market Analysis
5.7.1 Southeast Asia Insulin Active Pharmaceutical Ingredient Production
5.7.2 Southeast Asia Insulin Active Pharmaceutical Ingredient Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Insulin Active Pharmaceutical Ingredient Import and Export
5.8 India Insulin Active Pharmaceutical Ingredient Market Analysis
5.8.1 India Insulin Active Pharmaceutical Ingredient Production
5.8.2 India Insulin Active Pharmaceutical Ingredient Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Insulin Active Pharmaceutical Ingredient Import and Export

6 Insulin Active Pharmaceutical Ingredient Segment Market Analysis (by Type)
6.1 Global Insulin Active Pharmaceutical Ingredient Production by Type
6.2 Global Insulin Active Pharmaceutical Ingredient Revenue by Type
6.3 Insulin Active Pharmaceutical Ingredient Price by Type

7 Insulin Active Pharmaceutical Ingredient Segment Market Analysis (by Application)
7.1 Global Insulin Active Pharmaceutical Ingredient Consumption by Application
7.2 Global Insulin Active Pharmaceutical Ingredient Consumption Market Share by Application (2014-2019)

8 Insulin Active Pharmaceutical Ingredient Major Manufacturers Analysis
8.1 Novo Nordisk
8.1.1 Novo Nordisk Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
8.1.2 Novo Nordisk Product Introduction, Application and Specification
8.1.3 Novo Nordisk Insulin Active Pharmaceutical Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Insulin Active Pharmaceutical Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Tong Hua Dong Bao Group
8.3.1 Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
8.3.2 Tong Hua Dong Bao Group Product Introduction, Application and Specification
8.3.3 Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Wanbang Biopharmaceuticals
8.4.1 Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
8.4.2 Wanbang Biopharmaceuticals Product Introduction, Application and Specification
8.4.3 Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served

9 Development Trend of Analysis of Insulin Active Pharmaceutical Ingredient Market
9.1 Global Insulin Active Pharmaceutical Ingredient Market Trend Analysis
9.1.1 Global Insulin Active Pharmaceutical Ingredient Market Size (Volume and Value) Forecast 2019-2025
9.2 Insulin Active Pharmaceutical Ingredient Regional Market Trend
9.2.1 North America Insulin Active Pharmaceutical Ingredient Forecast 2019-2025
9.2.2 Europe Insulin Active Pharmaceutical Ingredient Forecast 2019-2025
9.2.3 China Insulin Active Pharmaceutical Ingredient Forecast 2019-2025
9.2.4 Japan Insulin Active Pharmaceutical Ingredient Forecast 2019-2025
9.2.5 Southeast Asia Insulin Active Pharmaceutical Ingredient Forecast 2019-2025
9.2.6 India Insulin Active Pharmaceutical Ingredient Forecast 2019-2025
9.3 Insulin Active Pharmaceutical Ingredient Market Trend (Product Type)
9.4 Insulin Active Pharmaceutical Ingredient Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Insulin Active Pharmaceutical Ingredient Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Insulin Active Pharmaceutical Ingredient
Table Global Insulin Active Pharmaceutical Ingredient Production (K MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Insulin Active Pharmaceutical Ingredient Production Market Share by Types in 2018
Figure Chemical Synthetics Product Picture
Figure Animal Extracts Product Picture
Table Global Insulin Active Pharmaceutical Ingredient Consumption (K MT) Comparison by Applications (2014-2025)
Figure Global Insulin Active Pharmaceutical Ingredient Consumption Market Share by Applications in 2018
Figure Animal Insulin
Figure Regular Human Insulin
Figure Insulin Analogue
Figure Global Insulin Active Pharmaceutical Ingredient Revenue (Million USD) (2014-2025)
Figure Global Insulin Active Pharmaceutical Ingredient Production (K MT) (2014-2025)
Figure North America Insulin Active Pharmaceutical Ingredient Market Size (Million USD) (2014-2025)
Figure Europe Insulin Active Pharmaceutical Ingredient Market Size (Million USD) (2014-2025)
Figure China Insulin Active Pharmaceutical Ingredient Market Size (Million USD) (2014-2025)
Figure Japan Insulin Active Pharmaceutical Ingredient Market Size (Million USD) (2014-2025)
Figure Southeast Asia Insulin Active Pharmaceutical Ingredient Market Size (Million USD) (2014-2025)
Figure India Insulin Active Pharmaceutical Ingredient Market Size (Million USD) (2014-2025)
Table Insulin Active Pharmaceutical Ingredient Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Insulin Active Pharmaceutical Ingredient in 2018
Figure Manufacturing Process Analysis of Insulin Active Pharmaceutical Ingredient
Figure Industry Chain Structure of Insulin Active Pharmaceutical Ingredient
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Insulin Active Pharmaceutical Ingredient Manufacturing Plants Distribution
Table Insulin Active Pharmaceutical Ingredient Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Insulin Active Pharmaceutical Ingredient Capacity (K MT) of Major Manufacturers (2014-2019)
Table Insulin Active Pharmaceutical Ingredient Production (K MT) of Major Manufacturers (2014-2019)
Table Insulin Active Pharmaceutical Ingredient Production Market Share of Major Manufacturers (2014-2019)
Figure Insulin Active Pharmaceutical Ingredient Production Share by Manufacturers in 2018
Table Insulin Active Pharmaceutical Ingredient Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Insulin Active Pharmaceutical Ingredient Revenue Market Share of Major Manufacturers (2014-2019)
Figure Insulin Active Pharmaceutical Ingredient Revenue Share by Manufacturers in 2018
Table Insulin Active Pharmaceutical Ingredient Average Price (USD/MT) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Insulin Active Pharmaceutical Ingredient Production by Regions 2014-2019 (K MT)
Table Global Insulin Active Pharmaceutical Ingredient Production Market Share by Regions 2014-2019
Figure Global Insulin Active Pharmaceutical Ingredient Production Market Share by Regions in 2018
Table Global Insulin Active Pharmaceutical Ingredient Revenue by Regions 2014-2019 (Million USD)
Table Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Regions 2014-2019
Figure Global Insulin Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2018
Table Global Insulin Active Pharmaceutical Ingredient Consumption by Regions 2014-2019 (K MT)
Table Global Insulin Active Pharmaceutical Ingredient Consumption Market Share by Regions 2014-2019
Figure North America Insulin Active Pharmaceutical Ingredient Production Growth Rate 2014-2019 (K MT)
Figure North America Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million USD)
Table North America Insulin Active Pharmaceutical Ingredient Production, Consumption Import and Export (K MT)
Figure Europe Insulin Active Pharmaceutical Ingredient Production Growth Rate 2014-2019 (K MT)
Figure Europe Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Insulin Active Pharmaceutical Ingredient Production, Consumption Import and Export (K MT)
Figure China Insulin Active Pharmaceutical Ingredient Production Growth Rate 2014-2019 (K MT)
Figure China Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million USD)
Table China Insulin Active Pharmaceutical Ingredient Production, Consumption Import and Export (K MT)
Figure Japan Insulin Active Pharmaceutical Ingredient Production Growth Rate 2014-2019 (K MT)
Figure Japan Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Insulin Active Pharmaceutical Ingredient Production, Consumption Import and Export (K MT)
Figure Southeast Asia Insulin Active Pharmaceutical Ingredient Production Growth Rate 2014-2019 (K MT)
Figure Southeast Asia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Insulin Active Pharmaceutical Ingredient Production, Consumption Import and Export (K MT)
Figure India Insulin Active Pharmaceutical Ingredient Production Growth Rate 2014-2019 (K MT)
Figure India Insulin Active Pharmaceutical Ingredient Revenue Growth Rate 2014-2019 (Million USD)
Table India Insulin Active Pharmaceutical Ingredient Production, Consumption Import and Export (K MT)
Figure Global Consumption Insulin Active Pharmaceutical Ingredient Market Share by Application (2014-2019)
Figure Global Value (Consumption) Insulin Active Pharmaceutical Ingredient Market Share by Application (2014-2019)
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Product Introduction, Application and Specification
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Production Growth Rate (2014-2019)
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Production Market Share (2014-2019)
Figure Novo Nordisk Insulin Active Pharmaceutical Ingredient Revenue Market Share (2014-2019)
Table Novo Nordisk Insulin Active Pharmaceutical Ingredient Main Business and Markets Served
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Product Introduction, Application and Specification
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Production Growth Rate (2014-2019)
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Production Market Share (2014-2019)
Figure Eli Lilly Insulin Active Pharmaceutical Ingredient Revenue Market Share (2014-2019)
Table Eli Lilly Insulin Active Pharmaceutical Ingredient Main Business and Markets Served
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Product Introduction, Application and Specification
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production Growth Rate (2014-2019)
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Production Market Share (2014-2019)
Figure Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Revenue Market Share (2014-2019)
Table Tong Hua Dong Bao Group Insulin Active Pharmaceutical Ingredient Main Business and Markets Served
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production Sites and Area Served
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Product Introduction, Application and Specification
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production (K MT), Revenue (Million USD), Ex-factory Price (USD/MT) and Gross Margin (2014-2019)
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production Growth Rate (2014-2019)
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Production Market Share (2014-2019)
Figure Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Revenue Market Share (2014-2019)
Table Wanbang Biopharmaceuticals Insulin Active Pharmaceutical Ingredient Main Business and Markets Served
Figure Global Insulin Active Pharmaceutical Ingredient Production (K MT) Growth Rate Forecast 2019-2025
Figure Global Insulin Active Pharmaceutical Ingredient Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Insulin Active Pharmaceutical Ingredient Sales Price (USD/MT) Forecast 2019-2025
Figure North America Insulin Active Pharmaceutical Ingredient Production Growth Rate Forecast 2019-2025 (K MT)
Figure North America Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Insulin Active Pharmaceutical Ingredient Production Growth Rate Forecast 2019-2025 (K MT)
Figure Europe Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Insulin Active Pharmaceutical Ingredient Production Growth Rate Forecast 2019-2025 (K MT)
Figure China Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Insulin Active Pharmaceutical Ingredient Production Growth Rate Forecast 2019-2025 (K MT)
Figure Japan Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Insulin Active Pharmaceutical Ingredient Production Growth Rate Forecast 2019-2025 (K MT)
Figure Southeast Asia Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Insulin Active Pharmaceutical Ingredient Production Growth Rate Forecast 2019-2025 (K MT)
Figure India Insulin Active Pharmaceutical Ingredient Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K MT) of Insulin Active Pharmaceutical Ingredient by Type (2019-2025)
Table Global Consumption (K MT) of Insulin Active Pharmaceutical Ingredient by Application (2019-2025)
Table Insulin Active Pharmaceutical Ingredient Distributors List
Table Insulin Active Pharmaceutical Ingredient Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---